Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goldhirsch

Showing results (221-230 of 753) with videos related to

Pageof 76
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 3, 1999
Quality of life assessment in the adjuvant setting: is it relevant? International Breast Cancer Study GroupR D Gelber, M Bonetti, B F Cole, et al.
The Medical Clinics of North America|October 9, 2002
Geriatric hospital medicineEileen H Callahan, David C Thomas, Suzanne L Goldhirsch, et al.
Lancet (London, England)|May 17, 2005
Prediction of cancer outcome with microarraysAron Goldhirsch, Richard D Gelber, Giuseppe Viale, et al.
Breast Cancer Research : BCR|January 12, 2005
The 6th Milan Breast Cancer Conference, Milan, Italy, 16-18 June 2004Roberto Gennari, Saverio Cinieri, Marco Colleoni, et al.
Schweizerische Medizinische Wochenschrift|October 22, 1983
[Ultrasonic diagnosis of ovarian carcinoma]U Herrmann, E Dreher, A Goldhirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Phase I study of the combination of monthly carboplatin and weekly cisplatinC Sessa, A Goldhirsch, G Martinelli, et al.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|April 19, 1983
[Adjuvant therapy in Operable non-small cell lung cancer]R Joss, E A Bleher, A Goldhirsch, et al.
Tumori|March 23, 2016
Response of extensive breast cancer skin metastases to rechallenge with trastuzumab together with low-dose chemotherapy and insulinLaura Orlando, Paola Schiavone, Nicola Calvani, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Quality of life in clinical trials of adjuvant therapies. International Breast Cancer Study Group (formerly Ludwig Group)R D Gelber, A Goldhirsch, C Hürny, et al.
Lancet (London, England)|November 10, 2000
Depression and degree of acceptance of adjuvant cytotoxic drugsM Colleoni, M Mandala, G Peruzzotti, et al.
Pageof 76

Showing results (221-230 of 753) with videos related to

Sort By:
Pageof 76
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 3, 1999
Quality of life assessment in the adjuvant setting: is it relevant? International Breast Cancer Study GroupR D Gelber, M Bonetti, B F Cole, et al.
The Medical Clinics of North America|October 9, 2002
Geriatric hospital medicineEileen H Callahan, David C Thomas, Suzanne L Goldhirsch, et al.
Lancet (London, England)|May 17, 2005
Prediction of cancer outcome with microarraysAron Goldhirsch, Richard D Gelber, Giuseppe Viale, et al.
Breast Cancer Research : BCR|January 12, 2005
The 6th Milan Breast Cancer Conference, Milan, Italy, 16-18 June 2004Roberto Gennari, Saverio Cinieri, Marco Colleoni, et al.
Schweizerische Medizinische Wochenschrift|October 22, 1983
[Ultrasonic diagnosis of ovarian carcinoma]U Herrmann, E Dreher, A Goldhirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Phase I study of the combination of monthly carboplatin and weekly cisplatinC Sessa, A Goldhirsch, G Martinelli, et al.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|April 19, 1983
[Adjuvant therapy in Operable non-small cell lung cancer]R Joss, E A Bleher, A Goldhirsch, et al.
Tumori|March 23, 2016
Response of extensive breast cancer skin metastases to rechallenge with trastuzumab together with low-dose chemotherapy and insulinLaura Orlando, Paola Schiavone, Nicola Calvani, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Quality of life in clinical trials of adjuvant therapies. International Breast Cancer Study Group (formerly Ludwig Group)R D Gelber, A Goldhirsch, C Hürny, et al.
Lancet (London, England)|November 10, 2000
Depression and degree of acceptance of adjuvant cytotoxic drugsM Colleoni, M Mandala, G Peruzzotti, et al.
Pageof 76